CELLECTIS SA Extends Its Technology Agreement With BASF Plant Science Gmbh For Marker Genes Excision In Crops
10/19/2005 5:10:10 PM
Cellectis SA, a biotechnology company specialized in genome engineering, announced today that the company was expanding its current agreement with BASF Plant Science GmbH. The agreement, covering the evaluation and use of Cellectis'proprietary Meganuclease I-SceI for the deletion/excision of nucleotide sequences, such as marker genes, in plants for agricultural and nutritional applications has been extended to further crops of interest for BASF Plant Science GmbH. Financial terms and conditions of the agreement were not disclosed.
comments powered by